11,535 Shares in Utah Medical Products, Inc. $UTMD Bought by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC purchased a new position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 11,535 shares of the medical instruments supplier’s stock, valued at approximately $726,000.

Other hedge funds also recently added to or reduced their stakes in the company. First Horizon Advisors Inc. boosted its stake in Utah Medical Products by 159.7% in the second quarter. First Horizon Advisors Inc. now owns 587 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 361 shares in the last quarter. CWM LLC raised its position in Utah Medical Products by 60.4% in the third quarter. CWM LLC now owns 1,330 shares of the medical instruments supplier’s stock worth $84,000 after acquiring an additional 501 shares in the last quarter. Cornerstone Planning Group LLC grew its position in Utah Medical Products by 3,272.5% during the third quarter. Cornerstone Planning Group LLC now owns 1,349 shares of the medical instruments supplier’s stock worth $85,000 after buying an additional 1,309 shares during the period. State of Wyoming purchased a new stake in Utah Medical Products during the second quarter worth $132,000. Finally, Russell Investments Group Ltd. lifted its holdings in shares of Utah Medical Products by 550.5% in the second quarter. Russell Investments Group Ltd. now owns 2,758 shares of the medical instruments supplier’s stock valued at $157,000 after purchasing an additional 2,334 shares in the last quarter. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Utah Medical Products Stock Down 0.1%

Utah Medical Products stock opened at $65.12 on Friday. The firm has a fifty day moving average of $62.23 and a 200-day moving average of $60.28. Utah Medical Products, Inc. has a 52-week low of $51.26 and a 52-week high of $68.71. The firm has a market capitalization of $208.38 million, a P/E ratio of 18.71 and a beta of 0.33.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings results on Thursday, January 29th. The medical instruments supplier reported $0.80 earnings per share for the quarter. Utah Medical Products had a net margin of 29.30% and a return on equity of 9.60%. The firm had revenue of $9.04 million during the quarter.

Utah Medical Products Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 3rd. Investors of record on Tuesday, March 17th will be paid a dividend of $0.31 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $1.24 annualized dividend and a yield of 1.9%. Utah Medical Products’s payout ratio is 35.63%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Utah Medical Products from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, February 25th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Utah Medical Products Company Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single?use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non?invasive monitoring products used in acute and long?term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end?tidal carbon dioxide (CO?).